OncoAlert and ecancer - ESMO 2021 Day 2

Share :
Published: 18 Sep 2021
Views: 821
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

Dr Gil Morgan from OncoAlert gives his insights on what to look out for from Day 2 of ESMO 2021.

Dr morgan mentions results from trials including VESPER, GIM4 and CheckMate 743.

He also reports that the results from the OncoAlert poster on attitudes towards the use of SBRT in oligometastatic breast cancer are out.

You can watch Dr Morgan's previous roundup here

Follow Dr Morgan on twitter: @OncoAlert

Follow ecancer on twitter: @ecancer

Search and follow #OncoAlertTopTweet to stay up to date.